Format

Send to

Choose Destination
J Dermatol Sci. 2017 Apr;86(1):3-12. doi: 10.1016/j.jdermsci.2016.10.004. Epub 2016 Oct 11.

Alopecia areata: What's new in epidemiology, pathogenesis, diagnosis, and therapeutic options?

Author information

1
Department of Dermatology, Kyoto University Graduate School of Medicine, Kyoto, Japan. Electronic address: dainichi@kuhp.kyoto-u.ac.jp.
2
Department of Dermatology, Kyoto University Graduate School of Medicine, Kyoto, Japan; Singapore Immunology Network (SIgN) and Institute of Medical Biology, Agency for Science, Technology and Research (A*STAR), Biopolis, Singapore; PRESTO, Japan Science and Technology Agency, Kawaguchi, Japan.

Abstract

Alopecia areata (AA) is a common and stressful disorder that results in hair loss, and resistant to treatment in some cases. Experimental and clinical evidence suggests that AA is caused by autoimmune attack against the hair follicles. The precise pathomechanism, however, remains unknown. Here, we focus on the recent progress in multidisciplinary approaches to the epidemiology, pathogenesis, and new treatments of AA in 996 publications from January 2010 to July 2016, and provide an overview of the current understanding in clinical management and research directions.

KEYWORDS:

Alopecia areata; Autoimmunity; Diagnosis; Epidemiology; Genetics; Treatment

PMID:
27765435
DOI:
10.1016/j.jdermsci.2016.10.004
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center